The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2012
Filed:
Apr. 29, 2005
James A. Burke, Santa Ana, CA (US);
Patrick M. Hughes, Aliso Viejo, CA (US);
Kai-ming Zhang, Irvine, CA (US);
Ton Lin, Irvine, CA (US);
Glenn Huang, Fremont, CA (US);
Brittany A. Jackson, Irvine, CA (US);
Larry A. Wheeler, Irvine, CA (US);
Rosy S. Donn, Saratoga, CA (US);
James A. Burke, Santa Ana, CA (US);
Patrick M. Hughes, Aliso Viejo, CA (US);
Kai-Ming Zhang, Irvine, CA (US);
Ton Lin, Irvine, CA (US);
Glenn Huang, Fremont, CA (US);
Brittany A. Jackson, Irvine, CA (US);
Larry A. Wheeler, Irvine, CA (US);
Rosy S. Donn, Saratoga, CA (US);
Allergan, Inc., Irvine, CA (US);
Abstract
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others or to improve vision in a normal eye.